| 10851171 |
Method for the selection of antibodies against BCMA |
Minh Diem Vu, Klaus Strein, Ekkehard Moessner, Ralf Hosse, Oliver Ast +5 more |
2020-12-01 |
| 10793621 |
Nucleic acid encoding dual Fc antigen binding proteins |
Birgit Bossenmaier, Hubert Kettenberger, Klaus-Peter Kuenkele, Joerg Thomas Regula, Wolfgang Schaefer +2 more |
2020-10-06 |
| 10781262 |
Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists |
Vaios Karanikas, Pablo Umana, Alfred Zippelius, Daniela Stefanie Thommen, Jens Schreiner |
2020-09-22 |
| 10781258 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Thomas Hofer, Ralf Hosse, Christiane Neumann, Ekkehard Moessner +2 more |
2020-09-22 |
| 10781257 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Thomas Hofer, Ralf Hosse, Christiane Neumann, Ekkehard Moessner +2 more |
2020-09-22 |
| 10766967 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Tanja Fauti, Sabine Imhof-Jung, Stefan Klostermann, Ekkehard Moessner +5 more |
2020-09-08 |
| 10683345 |
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases |
Harald Duerr, Frank Herting, Joerg Thomas Regula, Matthias Rueth, Kay-Gunnar Stubenrauch |
2020-06-16 |
| 10683369 |
Monoclonal antibodies against BCMA |
Minh Diem Vu, Klaus Strein, Oliver Ast, Marina BACAC, Camille DELON +6 more |
2020-06-16 |
| 10640555 |
Bispecific antigen binding proteins |
Sabine Imhof-Jung, Joerg Thomas Regula, Wolfgang Schaefer, Juergen Michael Schanzer |
2020-05-05 |
| 10633451 |
Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine |
Carole Bourquin, Raffaella Castoldi, Stefan Endres, Sebastian Kobold, Gerhard Niederfellner +1 more |
2020-04-28 |
| 10611825 |
Monovalent antigen binding proteins |
Birgit Bossenmaier, Hubert Kettenberger, Klaus-Peter Kuenkele, Joerg Thomas Regula, Wolfgang Schaefer +2 more |
2020-04-07 |
| 10611841 |
Bispecific T cell activating antigen binding molecules |
Oliver Ast, Marina BACAC, Sabine Imhof-Jung, Christiane Neumann, Stefan Klostermann +4 more |
2020-04-07 |
| 10611840 |
Bispecific T cell activating antigen binding molecules |
Oliver Ast, Marina BACAC, Sabine Imhof-Jung, Christiane Neumann, Stefan Klostermann +4 more |
2020-04-07 |
| 10603360 |
Combination IL-2 immunoconjugate therapy |
Christian Gerdes, Valeria G. Nicolini, Pablo Umana |
2020-03-31 |
| 10596257 |
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies |
Marina BACAC, Sara COLOMBETTI, Johannes SAM, Jose SARO, Pablo Umana |
2020-03-24 |
| 10584178 |
Bispecific HER2 antibodies and methods of use |
Rebecca CROASDALE-WOOD, Lydia Jasmin Hanisch, Guy Georges, Thomas Hofer, Ralf Hosse +7 more |
2020-03-10 |
| 10577429 |
Anti-FAP antibodies and methods of use |
Marina BACAC, Anne Freimoser-Grundschober, Ralf Hosse, Ekkehard Moessner, Valeria G. Nicolini +1 more |
2020-03-03 |
| 10562949 |
Interleukin-2 fusion proteins and uses thereof |
Ralf Hosse, Ekkehard Moessner, Laurence B. Peterson, Pablo Umana, Linda Wicker |
2020-02-18 |
| 10526413 |
Bispecific antibodies specific for OX40 |
Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +3 more |
2020-01-07 |